胰腺癌或胆管癌患者中分次团注与多期团注对比剂方案的比较
前瞻性研究纳入56例胰腺导管腺癌或胆管癌患者,分别采用本院标准多期团注方案(100 ml对比剂)与新型分次团注方案(110 ml)行增强CT。分次团注组总剂量长度乘积显著低于多期团注组(498.1 ± 43.7 mGy*cm vs 1,092.5 ± 106.9 mGy*cm,p < 0.001),除主动脉外关键解剖结构强化更高,主观图像质量与诊断准确率相当。
要点
- 分次团注方案总DLP为498.1 ± 43.7 mGy*cm,显著低于多期团注方案的1,092.5 ± 106.9 mGy*cm(p < 0.001)。
- 分次团注方案除主动脉外,门静脉、肝脏、胰腺等关键结构强化均高于多期团注方案。
- 分次团注方案每次检查所需层数显著更少(1,823 vs 3,235,p < 0.001)。
核心结论
- 分次团注方案在胰腺导管腺癌或胆管癌CT随访中提供与多期团注方案相同的图像质量和诊断准确率,同时显著降低辐射暴露。
研究设计与样本
- 前瞻性研究纳入56例患者,28例接受本院标准多期团注方案(100 ml对比剂团注),28例接受新型分次团注方案(110 ml),行增强CT检查。
关键影像表现/征象
- 分次团注组总剂量长度乘积为498.1 ± 43.7 mGy*cm,多期团注组为1,092.5 ± 106.9 mGy*cm(p < 0.001)。
- 分次团注组主动脉CT值为326.9 ± 15.7 HU,多期团注组为246.7 ± 12.2 HU(p < 0.001)。
- 分次团注方案除主动脉外,门静脉、肝脏和胰腺等所有关键解剖结构的对比强化均高于多期团注方案。
- 主观分析显示多期团注方案对重要标志(切除面 p = 0.624,门静脉 p = 0.395,肝脏 p = 0.361)的图像质量评分较差。
- 分次团注组每次检查所需层数为1,823层,多期团注组为3,235层(p < 0.001)。
诊断标准与关键数值
- 客观图像质量通过感兴趣区亨斯菲尔德单位衰减分析测量。
- 主观图像质量由两名盲法阅片者采用Likert量表评估。
- 诊断准确率及阅片者间变异性经统计学检验,两名盲法阅片者相关性显著,敏感度、特异度、阳性预测值、阴性预测值及总体阅片者间变异性均显著相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate the image quality, diagnostic accuracy, and dose reduction potential of a split-bolus protocol(SBP) compared with a multiphasic protocol(MPP) in the detection of recurrent or progressive pancreatic ductal adenocarcinoma(PDAC) or cholangiocarcinoma(CC) using contrast- enhanced computed tomography(CECT).
MATERIALS AND METHODS: This prospective study included 56 patients who underwent CECT, 28 with our institutional standard MPP(100 ml contrast bolus) and 28 with a novel SBP(110 ml). Radiation exposure was determined in terms of total dose- length product(DLP) and computed tomography dose index(CTDI). Image quality was measured objectively by analysis of attenuation in Hounsfield units(HU) in regions of interest(ROIs) and subjectively by two blinded readers using a Likert scale. Diagnostic accuracy and interreader variability were tested.
RESULTS: The total DLP of the SBP group(498.1 ± 43.7 mGy*cm) was significantly lower than in the MPP group(1,092.5 ± 106.9 mGy*cm; p < 0.001). The SBP showed higher contrast enhancement of all critical anatomical structures including portal vein, liver, and pancreas compared with the MPP, except for the aorta(SBP: 326.9 ± 15.7 HU vs. MPP: 246.7 ± 12.2 HU; p < 0.001). Subjective analysis revealed poorer image quality ratings for important landmarks with the MPP (resection surface: p = 0.624, portal vein: p = 0.395, liver p = 0.361). The two blinded readers correlated significantly. Sensitivity, specificity, positive and negative predictive values (PPV/NPV), and overall interreader variabilities correlated significantly. Furthermore, significantly fewer slices per exam were required for the SBP(1,823 vs. 3,235; p < 0.001).
CONCLUSION: The SBP provides the same image quality and diagnostic accuracy as an MPP while significantly lowering radiation exposure in CT follow-up of PDAC or CC.
引用
- Muenzfeld H, Mahjoub S, Roehle R, et al. Split-bolus vs. multiphasic contrast bolus protocol in patients with pancreatic cancer or cholangiocarcinoma. Eur J Radiol. 2019. PMID: 31430661. doi:10.1016/j.ejrad.2019.07.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。